Sho Nakakubo

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Coronavirus Disease

Body Mass Index

Ejection Fraction

Peritoneal Dialysis

Top Venues

Journal of medical virology

BMC infectious diseases

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Sho Nakakubo, Yoko Unoki, Koji Kitajima, Mari Terada, Hiroyuki Gatanaga, Norio Ohmagari, Isao Yokota, Satoshi Konno
Serum Lactate Dehydrogenase Level One Week after Admission Is the Strongest Predictor of Prognosis of COVID-19: A Large Observational Study Using the COVID-19 Registry Japan. Viruses 15 (3) (2023)
Sho Nakakubo, Yoko Unoki, Koji Kitajima, Mari Terada, Hiroyuki Gatanaga, Norio Ohmagari, Isao Yokota, Satoshi Konno
Serum Lactate Dehydrogenase Level One Week after Admission Is the Strongest Predictor of Prognosis of COVID-19: A Large Observational Study Using the COVID-19 Registry Japan. Viruses 15 (3) (2023)
Sho Nakakubo, Yoko Unoki, Koji Kitajima, Mari Terada, Hiroyuki Gatanaga, Norio Ohmagari, Isao Yokota, Satoshi Konno
Serum Lactate Dehydrogenase Level One Week after Admission Is the Strongest Predictor of Prognosis of COVID-19: A Large Observational Study Using the COVID-19 Registry Japan. Viruses 15 (3) (2023)
Yuki Hatakeyama, Sho Nakakubo, Hirotaka Kusaka, Naomi Watanabe, Yukinori Yoshida, Hitoshi Shinzaki, Hiromitsu Hiroumi, Naoki Kishida, Satoshi Konno
Listeria monocytogenes bacteremia mimicking the systemic metastasis of adrenal cancer: a case report. BMC infectious diseases 22 (1) (2022)
Yuichi Kojima, Sho Nakakubo, Nozomu Takei, Keisuke Kamada, Yu Yamashita, Junichi Nakamura, Munehiro Matsumoto, Hiroshi Horii, Kazuki Sato, Hideki Shima, Masaru Suzuki, Satoshi Konno
Comparative Efficacy of Tocilizumab and Baricitinib Administration in COVID-19 Treatment: A Retrospective Cohort Study. Medicina (Kaunas, Lithuania) 58 (4) (2022)
Yuichi Kojima, Sho Nakakubo, Keisuke Kamada, Yu Yamashita, Nozomu Takei, Junichi Nakamura, Munehiro Matsumoto, Hiroshi Horii, Kazuki Sato, Hideki Shima, Masaru Suzuki, Satoshi Konno
Combination therapy with remdesivir and immunomodulators improves respiratory status in COVID-19: A retrospective study. Journal of medical virology 94 (12) (2022)